Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Athenex Inc
(NQ:
ATNX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 24, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Athenex Inc
< Previous
1
2
Next >
Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
May 14, 2023
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business Update
March 20, 2023
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Announces a Reverse Stock Split
February 14, 2023
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Announces MHRA Decision on Oral Paclitaxel
January 03, 2023
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast Cancer
December 20, 2022
Oral Paclitaxel combination regimen has graduated in this Phase 2 trial in the triple negative breast cancer subgroup
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Exits 503B Sterile Compounding Business
December 16, 2022
Full-year 2022 product sales guidance maintained at 20-25% growth year-over-year
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Announces Positive Results of Special Stockholder Meeting
November 22, 2022
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Announces Closing of the Sale of its China API Business
November 21, 2022
From
Athenex, Inc.
Via
GlobeNewswire
Athenex to Participate in the 5th Annual Evercore ISI HealthCONx Conference
November 08, 2022
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Announces Receipt of Positive Nasdaq Listing Determination
November 03, 2022
Nasdaq Hearing Panel grants continued listing of Athenex and extension to regain compliance with the minimum bid price requirement
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Provides Third Quarter 2022 Financial Results and Business Update
November 03, 2022
From
Athenex, Inc.
Via
GlobeNewswire
Athenex to Provide Corporate and Financial Update for the Third Quarter 2022 on November 3, 2022
October 24, 2022
From
Athenex, Inc.
Via
GlobeNewswire
Athenex Files Definitive Proxy Statement for Special Stockholder Meeting
October 11, 2022
From
Athenex, Inc.
Via
GlobeNewswire
SHAREHOLDER ALERT: Robbins LLP is Investigating Athenex, Inc. (ATNX) for Shareholders
December 29, 2021
From
Robbins LLP
Via
Business Wire
SHAREHOLDER ALERT: Robbins LLP is Investigating Athenex, Inc. (ATNX) for Shareholders
June 07, 2021
From
Robbins LLP
Via
Business Wire
NASDAQ:ATNX Long Term Investor Notice: Investigation of Potential Wrongdoing at Athenex, Inc.
May 26, 2021
San Diego, CA -- (SBWIRE) -- 05/26/2021 -- Certain directors of Athenex, Inc. are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Increased R&D Activities Have Fueled Growth and Promise for Pancreatic Cancer Treatment
May 20, 2021
Via
FinancialNewsMedia
Topics
Death
Exposures
Death
DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
May 03, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 30, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
ATNX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Athenex, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: May 3, 2021
April 30, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 29, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athenex, Inc. (ATNX)
April 29, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Athenex, Inc. and Encourages Investors to Contact the Firm
April 28, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 28, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Bronstein, Gewirtz & Grossman, LLC Reminds Athenex, Inc. (ATNX) Shareholders of Class Action and Lead Plaintiff Deadline: May 3, 2021
April 28, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
NASDAQ:ATNX Investor Notice: Deadline on May 3, 2021 in Lawsuit Athenex, Inc.
April 27, 2021
San Diego, CA -- (SBWIRE) -- 04/27/2021 -- The Shareholders Foundation announced that a deadline is coming up on May 3, 2021 in the lawsuit filed for certain investors of Athenex, Inc. (NASDAQ:ATNX).
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 27, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 26, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against Athenex, Inc. (ATNX) and May 3 Deadline
April 26, 2021
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
MAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Athenex, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 23, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.